Bayer faces second investor reckoning over glyphosate litigation
The historic headquarters of German pharmaceutical and chemical maker Bayer AG is pictured in LeverkusenFRANKFURT (Reuters) - Bayer on Tuesday faces its second annual investor reckoning over its handling of a wave of U.S. lawsuits claiming its glyphosate-based weedkillers cause cancer.Criticism from investors at this year's annual shareholders' meeting -…
bubmagApril 28, 2020